Pharmaceutical Technology

FEBRUARY 18, 2023

The company offers generic medicines and biosimilars through Sandoz. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others.

Diabetes 40

Diabetes Generic Medicine Biosimilars Immunity 40

Pharmaceutical Technology

MAY 3, 2023

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

Express Pharma

JULY 3, 2023

India is known as the ‘Pharmacy of the World’, as the generic medicine supplier for over 200 countries, both developed and emerging markets. A large presence of local players producing branded generics, along with lower price levels, has provided India with a unique opportunity. How poised are you to leverage them?

Biosimilars 95

Biosimilars Drug Development Generic Medicine Diabetes 95

European Pharmaceutical Review

APRIL 25, 2024

Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for generic medicines will be a significant factor for growth.

Packaging 98

Packaging Generic Medicine Diabetes Vaccines 98

Express Pharma

JUNE 12, 2024

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

Generic Medicine 105

Generic Medicine Vaccines Diabetes Immunization 105

Express Pharma

JUNE 21, 2024

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

Generic Medicine 102

Generic Medicine Vaccines Diabetes Immunization 102

Express Pharma

NOVEMBER 1, 2024

Dr Venkateswaran points to the innovative use of GLP-1 agonists, initially anti-diabetic drugs, now repurposed as anti-obesity treatments. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.

Drug Development 111

Drug Development Compounding Generic Medicine Vaccines 111

Quality Matters

OCTOBER 13, 2021

Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient. A study conducted by researchers from Johns Hopkins University found that drugs with a USP monograph had 50% more manufacturers than drugs without a USP monograph.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Express Pharma

SEPTEMBER 11, 2023

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Annually, about 2,827 brands with a total value of Rs. 3,810 crores were introduced.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

Drug Patent Watch

JANUARY 23, 2025

Governments and healthcare systems in these regions are looking for cost-effective solutions to address the growing burden of non-communicable diseases, such as diabetes, cardiovascular disease, and cancer. Generic drugs offer a viable solution, providing high-quality treatments at a fraction of the cost of branded medicines.

Drug Development 73

Drug Development Generic Medicine Communication Diabetes 73